Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Mexico Tech Monitor.
Press releases published on August 28, 2025
Xtract One Selected by Temple University to Fortify Security at The Liacouras Center
GlobeNewswire
·
August 28, 2025
TORONTO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced its SmartGateway system has been selected by Temple University (“Temple”), located in Philadelphia, PA, …
Kura Oncology to Participate in Three Upcoming Investor Conferences
GlobeNewswire
·
August 28, 2025
SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that management is scheduled …
Zevra Therapeutics Announces Multiple Datasets on MIPLYFFA® (arimoclomol) to be Presented at the International Congress of Inborn Errors of Metabolism (ICIEM)
GlobeNewswire
·
August 28, 2025
CELEBRATION, Fla., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced four posters on MIPLYFFA® …
Draganfly Announces Expansion of U.S. Manufacturing Footprint and Capacity to Meet Demand for Scalable U.S.-Made Drone Solutions
GlobeNewswire
·
August 28, 2025
Tampa, Florida, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an industry-leading developer of drone solutions and systems, is pleased to announce the expansion of its U.S. …
Akero Therapeutics to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
GlobeNewswire
·
August 28, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today …
Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025
GlobeNewswire
·
August 28, 2025
CHAPEL HILL, N.C., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies, …
AAVantgarde to Present Updated Clinical Data from LUCE-1 Study at EURetina 2025
GlobeNewswire
·
August 28, 2025
MILAN, Aug. 28, 2025 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company developing next-generation gene therapies for inherited retinal diseases, today announced the presentation of updated LUCE-1 clinical data at the …
Cartesian Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 28, 2025
FREDERICK, Md., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced that its management expects to …
FactSet Schedules Fourth Quarter 2025 Earnings Call
GlobeNewswire
·
August 28, 2025
NORWALK, Conn., Aug. 28, 2025 (GLOBE NEWSWIRE) -- FactSet (NYSE: FDS | NASDAQ: FDS), a global financial digital platform and enterprise solutions provider, today announced it will release its financial results for the fourth quarter fiscal 2025, ending …
Tilray Medical Expands Presence in Germany with Introduction of New Good Supply Medical Cannabis Strains
GlobeNewswire
·
August 28, 2025
LONDON and NEUMÜNSTER, Germany, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and …
Tonix Pharmaceuticals to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2025
GlobeNewswire
·
August 28, 2025
CHATHAM, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biotechnology company with marketed products and a pipeline of development candidates, today announced that …
Questor Announces Second Quarter Results
GlobeNewswire
·
August 28, 2025
CALGARY, Alberta, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Questor Technology Inc. (“Questor” or the “Company”) (TSX-V: QST) announced today its financial and operating results for the second quarter ended June 30, 2025. Questor’s unaudited Condensed …
CTW Launches Pre-Registration for Simulation Game Adaptation of Hit Anime The Apothecary Diaries
GlobeNewswire
·
August 28, 2025
TOKYO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- CTW Cayman (Nasdaq: CTW) (“CTW” or “the Company”), a leading game platform company providing global access to web-based games through its flagship HTML5 platform, G123.jp, which showcases a diverse selection of free …
Aduro Clean Technologies Reports Fourth Quarter and Fiscal Year 2025 Results and Provides Business Update
GlobeNewswire
·
August 28, 2025
LONDON, Ontario, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste …
Trident's DRC Pass Digital Identity System Recognized at Africa Singapore Business Forum as Model for International Collaboration
GlobeNewswire
·
August 28, 2025
SINGAPORE, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Trident Digital Tech Holdings Ltd. (“Trident” or the “Company,” NASDAQ: TDTH), a Singapore-based catalyst for digital transformation and Web 3.0 activation, was prominently featured during the Africa Singapore …
SciSparc Shareholders Approve Merger with a Leading Parallel Vehicle Importer in Israel
GlobeNewswire
·
August 28, 2025
TEL AVIV, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, …
Outlook Therapeutics Provides Regulatory Update on U.S. Food and Drug Administration Review of ONS-5010/LYTENAVA™ (bevacizumab-vikg) for the Treatment of Wet AMD
GlobeNewswire
·
August 28, 2025
FDA issues Complete Response Letter (CRL) for resubmitted ONS-5010 BLA Outlook Therapeutics plans to work with FDA to address the Agency’s issues Company to host a conference call and webcast today, August 28th at 8:30 AM ET ISELIN, N.J., Aug. 28, 2025 ( …
Sai Life Sciences completes Phase II of Production Block 11 at Bidar site, India, expands capacity to 700 KL
GlobeNewswire
·
August 28, 2025
HYDERABAD, India, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the completion of Phase II of its new …
Oculis to Participate in Upcoming September Investor Conferences
GlobeNewswire
·
August 28, 2025
ZUG, Switzerland, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on developing innovative solutions for ophthalmic and neuro-ophthalmic diseases with significant unmet …
Aurora Mobile Limited Announces Second Quarter 2025 Unaudited Financial Results
GlobeNewswire
·
August 28, 2025
SHENZHEN, China, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (“Aurora Mobile” or the “Company”) (NASDAQ: JG), a leading provider of customer engagement and marketing technology services in China, today announced its unaudited financial results …